Director's Message, Spring 2017

I am pleased to announce our participation in two new NIH initiatives that create nationwide networks to support critical facets of clinical trials: The Trial Innovation Network (TIN) and the Accrual to Clinical Trials program (ACT). UC San Diego Altman Clinical and Translational Research Institute (ACTRI) serves as the local link to these exciting new efforts. Read more from Director Gary S. Firestein, MD

News and Features: